NeuroProof GmbH is a leading global contract research organization specializing in microelectrode array (MEA)-based phenotypic screening of neuronal cultures. With state-of-the-art mathematical expertise, NeuroProof offers screening services for the preclinical development of neuro-pharmaceuticals. They provide the growing of neuronal cultures on MEA chips, medium-throughput screening of test agents, high-quality recording of network activity, and advanced mathematical analysis.

Their unique platform allows for the identification and characterization of test agents' effects on neuronal network activity, synaptogenesis, and behavioral connectivity. NeuroProof has extensive experience with various primary neuronal cell cultures and human neuronal stem cells. They use proprietary pattern recognition algorithms to compare compounds' phenotypic profiles and assess new applications, repositioning, or potential adverse effects.

Their services also assess neuronal maturation, synaptogenesis, and the differentiation process of human stem cell cultures. With NeuroProof, you can partner in developing innovative in vitro disease models and advancing the field of neuro-pharmaceuticals. Contact them at infobox@neuroproof.

com or +49 381 54345-660 for more information